Regulations VS. Innovation – Is Sustainability Stifling Progress in Life Sciences

How can organizations navigate the complexities of the evolving sustainability regulatory framework and ensure they are future-ready for forthcoming regulations?

The life sciences industry, a pivotal player in promoting human health and well-being, is transforming toward sustainability. With its significant contribution of 4.5% to global CO2 emissions, the urgency to embrace sustainable practices has never been more pressing. This shift extends beyond mere compliance; it necessitates a comprehensive reevaluation of risk management strategies and long-term positioning within an ever-evolving regulatory landscape.

Watch to Explore:

• The dynamic and evolving regulatory landscape shapes sustainability within the life sciences sector, including regulations like the EU Regulations on Deforestation-free Products (EUDR) impacting various commodities for brands.
• Explore the tangible implications of these regulations on various stakeholders within the industry, from pharmaceutical manufacturers to biotechnology firms and beyond. Discuss the challenges faced by companies in the supply chain in sourcing sustainable materials, navigating complex compliance requirements, and ensuring transparency.
• Discover the impact of initiatives such as the Carbon Border Adjustment Mechanism (CABM) on relevant commodities, and how it affects global trade dynamics and sustainability efforts.
• Understand the implications of regulations like the European Single-Use Plastics Directive (SUPD) and the broader effect of changing regulatory landscapes on the industry as a whole, from product design to manufacturing processes and consumer behavior.

Receive key recommendations on proactively preparing your organization for forthcoming regulations, including exploring alternative substances, implementing strategic sustainability initiatives, collaborating with sustainable supply chain partners, and leveraging cutting-edge technologies.